Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial-Reference-Cited by-同舟云学术

Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial

Published:2002-10 Issue:4 Volume:144 Page:589-596
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Tardif Jean-Claude,Grégoire Jean,Lespérance Jacques,Lambert Jean,L'Allier Philippe L.,Rodés Josep,Anderson Todd,Blue John W.,Imus James,Heinonen Therese

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture;Moreno;Circulation,1994

2. Rat liver acyl-coenzyme A: cholesterol acyltransferase: its regulation in vivo and some of its properties in vitro;Erickson;J Lipid Res,1980

3. Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions: a biochemical, morphological and morphometric evaluation;Bocan;Arterioscler Thromb,1991

4. The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits;Bocan;Arterioscler Thromb Vasc Biol,2000

5. Acyl-CoA: cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in apo E3-Leiden mice;Delsing;Circulation,2001

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Sterol O-Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): A Perspective on Small-Molecule Inhibitors and Their Therapeutic Potential;Journal of Medicinal Chemistry;2022-12-06

2. ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future;Current Atherosclerosis Reports;2022-05-07

3. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial;European Heart Journal;2014-04-29

4. HPLC-FLD determination of NBD-cholesterol, its ester and other metabolites in cellular lipid extracts;Biomedical Chromatography;2013-03-25

5. Transient Impairment of Vasomotion Function After Successful Chronic Total Occlusion Recanalization;Journal of the American College of Cardiology;2012-02